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 Current global estimates indicate that some 
150 million people consume groundwater 
containing arsenic concentrations above the 
WHO-limit of 10µg/L (Ucuncu et al., 2018; 
Izah and Srivastav, 2015; Ravenscroft et al., 
2009). The relative toxicity of arsenic de-
pends primarily on the inorganic or anionic 
form, oxidation state, solubility, physical 
state and rates of absorption which can vary 
greatly in arsenic compounds; in general ar-
senic compounds can be ranked from high-
est to lowest toxicityin the following order: 
inorganic trivalent compounds > organic 
ABSTRACT 
This study was conducted to investigate the time-course effects of low levels of organic arsenic on 
electrolytes balance and lipid profiles in different organs of male rats. Animals were exposed to arsenic 
(As) as Dimethylarsenate (DMA) in their drinking water for 5, 10 and 15 weeks at doses 20 and 40 
ppm. Lipids (Triacylglycerol (TAG), total cholesterol, phospholipids) and electrolytes (sodium, potassi-
um, magnesium, calcium) levels were determined in the hepatic, renal, brain and cardiac tissues of 
experimental animals. Potassium significantly (p<0.05) increased in the hepatic, renal and cardiac 
tissues after 5 weeks exposure to 40 ppm arsenic. Significant (p<0.05) increase observed in hepato-
cytes calcium level was shown to be dose-dependent. While there was no observed significant 
(p>0.05) difference in hepatic and renal magnesium after 15 weeks exposure, magnesium significantly 
altered in the brain and cardiac tissues after 15 weeks. TAG concentration in most of the organs stud-
ied was significantly (p<0.05) altered after 5 weeks exposure to 20 ppm arsenic. Phospholipids in the 
renal and hepatic tissues were also significantly (p<0.05) decreased after 15 weeks of exposure to As. 
However, only in the renal tissues was hypocholesterolemia observed in 40 ppm groups at 5, 10 and 
15 weeks of exposure. Our findings indicate exposure to progressively low-levels arsenic can result in 
electrolytes imbalance and dyslipidemia in different organs in rats. 
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INTRODUCTION 
Arsenic is a metalloid, which possesses 
characteristics of both a metal and a non-
metal and is widely distributed in the soil, 
water, air and rocks (Hong et al., 2014). 
Man’s continuous activities mediate the ef-
flux of this element into the atmosphere 
and environment thus increasing its availa-
bility and hence toxicity (Izah and Srivastav, 
2015; Obinaju, 2009).Exposure to arsenic is 
mainly through food and drinking water 
(Mandal, 2017). 
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trivalent > inorganic pentavalent com-
pounds > organic pentavalent compounds 
> elemental arsenic (Gorby, 1988).  
 
Occupational exposure to arsenic among 
workers in a glass plant in India whose 
blood arsenic were five times higher than in 
the control group was reported to lead to 
increased DNA damage in leukocytes (Liu et 
al., 2016; Vuyyuri et al., 2006). The genotox-
icity of organic arsenic has also been thor-
oughly investigated (Eckstein et al., 
2017;Kuroda et al., 2004). Arsenic exposure 
has been linked with various types of cancer 
(Mandal, 2017; Monrad et al., 2017; Miller et 
al., 2002; Tseng et al., 1968), cardiovascular 
disease (Valko et al., 2016; Abdul et al., 2015; 
Afolabi et al., 2014: Nava-Acien et al., 2005), 
diabetes (Grau-Perez et al, 2017; Diaz-
Villasenor et al., 2007), neurological disor-
ders (Tyler and Allan, 2014; Valudnia et al., 
2007) and dermal effects (Cohen et al., 
2006), work is still on-going to discover the 
mechanism of action of arsenic in causing 
these deleterious effects.  
In this study we investigated the time 
course effects of low level arsenic exposure 
on the electrolyte concentrations and lipids 
profile in some organs in male albino rats. 
 
MATERIALS AND METHODS 
Chemicals  
Dimethylarsenate (DMA) used was ob-
tained from Sigma chemicals company 
St.Louis, MO USA. Other reagents used 
were of analytical grade and were prepared 
using distilled water. 
 
Animals 
Adult male albino rats with an average 
weight of 150g, obtained from the Depart-
ment of Zoology, University of Ibadan, Ni-
geria were used for this research. Rats were 
housed in plastic cages maintained at 
25±2ºC and 12 hours light were given free 
access to food and water ad libitum.  
 
Animals were grouped into nine (9) groups 
of five (5) rats each. Groups I, IV and VII 
served as control groups for 5, 10 and 15 
weeks Dimethylarsenate (DMA) exposure 
respectively. Groups II, V and VIII were 
exposed to 20ppm arsenicas DMA for 5, 10 
and 15 weeks respectively while groups III, 
VI and IX were given 40ppm arsenic as 
DMA. Animals were exposed to arsenic 
through their drinking water. 
 
Sample Collection and Analyses 
Animals were sacrificed under light diethyl 
ether anesthesia. Blood samples were collect-
ed from the abdominal artery into hepa-
rinized tubes while the kidney, brain, heart 
and liver tissues were harvested into physio-
logical saline and then blotted dried. The 
blood samples were centrifuged at 4,000 rpm 
from 5 minutes to obtain the plasma (upper 
layer) used for analysis. Homogenate (10%) 
of the organs was obtained using 0.25M Su-
crose. Chloroform-methanol mixture (2:1 v/
v) was used to obtain the 10% homogenate 
used for lipid analysis according to the meth-
od described by Folch et al. (1957). 
 
Biochemical analyses 
Lipid indices such as triacylglycerols (TAG), 
cholesterol and phospholipids concentra-
tions were determined in the lipid extracts 
using methods described by Bucolo and Da-
vid, 1973; Allain et al. (1974) and Stewart 
(1980) respectively.   
 
Briefly, TAG concentration was determined 
based on the enzymatic hydrolysis of triglyc-
erides to glycerol and free fatty acids (FFA) 
by lipoprotein lipase (LPL). The glycerol is 
phosphorylated by adenosine triphosphate 
(ATP) in the presence of glycerolkinase 
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(GK) to form glycerol-3-phosphate (G-3-P) 
and adenosine diphosphate (ADP). G-3-P is 
oxidized by glycerophosphate oxidase 
(GPO) to form dihydroxy acetone 
phosphate (DHAP) and hydrogen peroxide. 
Cholesterol concentration was determined 
after enzymatic hydrolysis and oxidation of 
cholesteryl esters. The indicator 
quinonemine concentration is then 
measured spectrophotometrically which 
correlates to the concentration of 
cholesterol concentrat ion in the 
sample.Phospholipids concentration was 
assayed based on complex formation 
between ammonium ferrothiocyanate and 
phospholipids. 
 
Electrolytes which include sodium (Na+), 
potassium (K+), calcium (Ca2+) and magne-
sium (Mg2+) levels were determined using 
the methods described by Trinder (1951), 
Terri and Sesin (1958), Tietz (1995) and 
Chromya et al. (1973) respectively. Briefly, 
Na+in the sample was precipitated as a tri-
ple salt, the excess uranium was then react-
ed with ferrocyanide to produce achromo-
phore whose absorbance varies inversely 
with the concentration of Na+present in the 
sample. Likewise, K+ was determined after 
precipitation of the proteins, by using sodi-
umtetraphenylboron in an alkaline medium 
to produce a colloidalsuspension. The tur-
bidity formed is proportional to 
K+concentration in the sample, and was 
measuredspectrophometrically. Ca2+ reacts 
with Arsenazo 111{1,8-Dihydroxy-3,6-
disulpho-2,7-naphthalene-bis (azo)-
dibenzenearsonic acid} at neutralpH, to 
yield a bluecoloured complex whose intensi-
ty is proportional to the Ca2+ concentration 
in the sample, whileMg2+ forms a coloured 
complex when treated with xylidyl blue in 
alkaline solution. The intensity of the colour 
is proportional to the concentration in the 
sample. 
 
Statistical Evaluation  
Values are expressed as mean ± S.E.M. The 
data were statistically analyzed using analysis 
of variance (ANOVA). The level of homoge-
neity among the groups was tested using 
Duncan’s multiple range test (DMRT). 
P<0.05 were considered to be significant. 
 
RESULTS 
In the hepatic tissues (Table 1), after 15 
weeks of exposure, there was no significant 
difference in the total cholesterol concentra-
tion; however, our results revealed that 
chronic exposure to 40ppm arsenic results in 
a significant reduction in TAG and phospho-
lipids levels. In the renal tissues, TAG and 
cholesterol concentrations were significantly 
reduced after 5 weeks exposure to 40ppm 
arsenic(Table 2), however, all lipids indices 
measured in this study were significantly re-
duced in the renal tissues after 15 weeks of 
exposure to arsenic as shown in Table 2. Re-
sults indicated 20 and 40ppm doses of arse-
nic had no significant effect on cholesterol 
and phospholipids levels of the brain after 
15 weeks although TAG level was decreased 
significantly with 54.4% when compared 
with the control group (Table 3). In the car-
diac tissues (Table 4) while phospholipids 
level was significantly increased in 40ppm 
group after 15 weeks exposure to the toxi-
cant, TAG level was decreased. 
 
From Table 5 results showed significant in-
crease in Na+ level (40ppm for 15 weeks) 
and Ca2+ level (all through the course of ex-
posure) in the hepatic tissues. Mg2+ and K+ 
levels were decreased after 10 weeks and 15 
weeks respectively. In the renal tissues, all 
electrolytes studied except Mg2+ decreased 
significantly after 15 weeks of exposure. In 
the brain tissues, Na+, K+ and Mg2+ were 
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significantly increased however, the increase 
observed in Na+ and K+ levels was from 10 
weeks exposure while Mg 2+ was increased 
after 15 weeks (Table 7). In Table 8, Ca2+ 
level of the cardiac tissue decreased in 
40ppm exposed group. Although K+ in-
creased for the first 10 weeks of exposure, 
after 15 weeks there was a significant reduc-
tion of 26.7% and 60% in 20 and 40ppm 
groups respectively. There was no observa-
ble pattern of change for cardiac Mg2+on 
exposure to arsenic. 
Duration Group Total Cholesterol Triacylglycerol
(TAG) 
phospholipids 
5 weeks Control 12.39±0.96a 4.38±0.27a 18.09±1.38a 
  20ppm 11.08±0.96a 8.60±0.21b 16.14±1.21a 
  40ppm 8.78±0.48b 12.80±0.84c 17.33±1.14a 
10 weeks Control 14.68±1.33a 7.05±0.59a 15.43±0.68a 
  20ppm 13.30±0.63b 8.99±0.43b 19.45±2.16b 
  40ppm 16.89±1.72a 7.07±1.00ab 21.74±0.82b 
15 weeks Control 11.74±1.09a 6.20±0.57a 22.87±0.78a 
  20ppm 13.57±2.03a 6.76±0.24a 18.16±2.06b 
  40ppm 11.62±0.88a 4.01±0.14b 5.95±1.06c 
Values are expressed as mean ± standard error of mean (S.E.M). Values with different superscript 
within the same column in the same group are significantly different (p<0.05). 
Table 2: Effects of Arsenic on Renal Lipid Profiles (mg/g of organ) 
Duration Group Total Cholesterol Triacylglycerol 
(TAG) 
phospholipids 
5 weeks Control 14.45±0.85a 8.52±0.33a 23.70±2.10a 
  20ppm 14.16±0.45a 9.49±1.35a 24.00±2.89a 
  40ppm 7.81±0.76 b 4.97±0.085b 23.70±2.03a 
10 weeks Control 20.92±2.87a 9.68±0.66a 18.56±1.01a 
  20ppm 13.95±0.93b 8.79±0.35ab 21.58±1.16 ab 
  40ppm 15.08±0.58b 9.33±0.91ab 24.99±0.88b 
15 weeks Control 29.71±1.54a 12.73±0.50a 24.92±2.01a 
  20ppm 15.73±4.11b 9.59±0.47 b 18.33±1.77b 
  40ppm 17.50±0.90b 9.33±0.91b 10.16±0.83c 
Values are expressed as mean ± standard error of mean (S.E.M). Values with different su-
perscript within the same column in the same group are significantly different (p<0.05). 
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Table 3: Effects of arsenic on lipid profiles of the brain tissues (mg/g of organ) 
Duration Group Total Cholesterol Triacylglycerol 
(TAG) 
phospholipids 
5 weeks Control 12.21±0.53a 12.04±3.33a 27.99±3.48a 
  20ppm 10.53±0.33a 7.90±0.52 b 31.94±2.25a 
  40ppm 20.78±4.83b 6.36±0.52b 29.85±0.46a 
10 weeks Control 24.24±5.11a 10.12±1.72a 29.34±0.42a 
  20ppm 18.44±2.61a 8.75±0.15 a 30.47±0.48a 
  40ppm 14.92±1.86a 9.75±1.05a 30.22±0.49a 
15 weeks Control 22.42±2.23a 10.77±0.23a 28.54±1.64a 
  20ppm 24.92±0.73a 13.84±2.34a 29.96±2.36a 
  40ppm 23.27±0.70a 4.91±0.44b 24.96±2.36a 
Values are expressed as mean ± standard error of mean (S.E.M). Values with different  
superscript within the same column in the same group are significantly different (p<0.05). 
Table 4: Effects of Arsenic on Cardiac Lipid Profiles (mg/g of organ) 
  Group Total Cholesterol Triacylglycerol 
(TAG) 
phospholipids 
5 weeks Control 10.92±1.10a 6.38±0.36a 18.21±1.64a 
  20ppm 9.31±0.43a 11.97±1.20 b 18.04±0.50a 
  40ppm 12.54±1.29a 15.05±0.72b 19.55±1.37a 
10 weeks Control 9.95±0.46a 7.78±0.58a 15.02±0.65a 
  20ppm 11.08±0.85a 7.73±0.31a 20.79±2.30b 
  40ppm 9.51±0.27a 6.77±0.26a 20.69±0.75b 
15 weeks Control 11.97±0.56a 5.87±0.78a 20.25±1.30a 
  20ppm 10.06±0.96a 5.79±0.97a 18.09±0.58a 
  40ppm 10.45±0.50a 4.76±0.27b 28.20±1.44b 
Values are expressed as mean ± standard error of mean (S.E.M). Values with different  
superscript within the same column in the same group are significantly different (p<0.05). 
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Table 5: Effects of arsenic on hepatic electrolytes 
  Groups Na+ 
(mEq/g) 
K+ 
(mEq/g) 10-2 
Ca2+ 
(mg/g) 
Mg2+ 
(mg/g) 
5 weeks Control 
20ppm 
40ppm 
0.31±0.04a 
0.37±0.04a 
0.28±0.02a 
3.00±0.10a 
3.00±0.20a 
4.00±0.10b 
0.35±0.05a 
0.52±0.05b 
0.65±0.02b 
0.07±0.01a 
0.08±0.01a 
0.09±0.02a 
10 weeks Control 
20ppm 
40ppm 
0.28±0.14a 
0.34±0.02a 
0.49±0.04b 
3.00±0.40a 
4.00±0.04c 
4.00±0.05c 
0.34±0.05a 
0.66±0.07b 
0.69±0.06b 
0.15±0.01a 
0.10±0.01b 
0.11±0.01b 
15 weeks Control 
20ppm 
40ppm 
0.26±0.02a 
0.24±0.02a 
0.53±0.03b 
5.00±0.40a 
2.00±0.20b 
2.00±0.10b 
0.36±0.04a 
0.70±0.03b 
0.84±0.04b 
0.17±0.01a 
0.19±0.00a 
0.18±0.01a 
Values are expressed as mean ± S.E.M. values with different superscript within the same 
column in the same group are significantly (p<0.05) ­different. 
Table 6: Effects of arsenic on renal electrolytes 
  Groups Na+ 
(mEq/g) 
K+ 
(mEq/g) 10-2 
Ca2+ 
(mg/g) 
Mg2+ 
(mg/g) 
5 weeks Control 
20ppm 
40ppm 
1.35±0.01a 
1.46±0.04a 
1.20±0.05a 
2.30±0.10a 
2.00±0.10a 
3.50±0.03b 
0.65±0.07a 
0.41±0.05b 
0.29±0.05b 
0.10±0.01a 
0.09±0.01a 
0.09±0.02a 
10 weeks Control 
20ppm 
40ppm 
0.89±0.04a 
0.99±0.02a 
0.78±0.03a 
3.40±0.30a 
3.30±0.10a 
3.90±0.01b 
0.41±0.02a 
0.37±0.09a 
0.31±0.07a 
0.15±0.03a 
0.12±0.00b 
0.12±0.00b 
15 weeks Control 
20ppm 
40ppm 
0.72±0.04a 
0.21±0.02b 
0.27±0.03b 
3.90±0.00a 
1.60±0.03b 
1.70±0.10b 
0.72±0.05a 
0.40±0.04b 
0.26±0.04b 
0.17±0.01a 
0.17±0.00a 
0.17±0.01a 
Values are expressed as mean ± S.E.M. values with different superscript within the same 
column in the same group are significantly (p<0.05) different. 
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Table 7: Effects of arsenic on electrolytes of the brain tissues 
  Groups Na+ 
(mEq/g) 
K+ 
(mEq/g) 
10-2 
Ca2+ 
(mg/g) 
Mg2+ 
(mg/g) 
5 weeks Control 
20ppm 
40ppm 
1.08±0.03a 
1.15±0.07a 
1.03±0.04a 
2.70±0.10a 
2.90±0.10a 
3.00±0.10a 
0.75±0.08a 
0.56±0.04b 
0.53±0.06b 
0.07±0.01a 
0.07±0.00a 
0.08±0.01a 
10 weeks Control 
20ppm 
40ppm 
0.89±0.04a 
1.17±0.08b 
1.11±0.09b 
3.30±0.20a 
3.00±0.10a 
3.90±0.03b 
0.40±0.03a 
0.57±0.06a 
0.39±0.11a 
0.16±0.01a 
0.13±0.01a 
0.15±0.00a 
15 weeks Control 
20ppm 
40ppm 
0.87±0.06a 
1.21±0.02b 
1.26±0.02b 
3.20±0.10a 
2.10±0.10b 
1.80±0.10b 
0.51±0.03a 
0.56±0.03a 
0.46±0.03a 
0.15±0.01a 
0.17±0.00b 
0.17±0.01b Values are expressed as mean ± S.E.M. values with different superscript within the same 
column in the same group are significantly (p<0.05) different. 
Table 8: Effects of arsenic on cardiacelectrolytes 
  Groups Na+ 
(mEq/g) 
K+ 
(mEq/g) 10-2 
Ca2+ 
(mg/g) 
Mg2 
(mg/g) 
5 weeks Control 
20ppm 
40ppm 
0.58±0.13a 
0.70±0.22a 
0.70±0.19a 
2.40±0.10a 
2.80±0.20b 
3.20±0.10b 
0.65±0.06a 
0.63±0.03a 
0.49±0.04b 
0.08±0.01b 
0.05±0.00a 
0.09±0.01b 
10 weeks Control 
20ppm 
40ppm 
0.88±0.11a 
0.61±0.15a 
0.81±0.13a 
3.50±0.10a 
3.70±0.10a 
3.90±0.02b 
0.50±0.04a 
0.54±0.09a 
0.33±0.99b 
0.16±0.02a 
0.09±0.00b 
0.11±0.00b 
15 weeks Control 
20ppm 
40ppm 
1.02±0.19a 
1.21±0.19a 
1.44±0.17a 
3.00±0.40a 
2.20±0.10b 
1.20±0.10b 
0.57±0.04a 
0.53±0.02a 
0.42±0.02b 
0.10±0.00a 
0.18±0.00b 
0.18±0.00b Values are expressed as mean ± S.E.M. values with different superscript within the same 
column in the same group are significantly (p<0.05) different. 
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DISCUSSION 
Arsenic has been reported to cause oxida-
tive stress thus induction of several reactive 
oxygen species (ROS) which ultimately 
leads to cell damage (Ghulam et al., 2018; 
Chandrakar et al., 2017; Vizcaya-Ruiz et 
al.,2009). Lipids are one of the most suscep-
tible targets of free radicals (Mushtaq et al., 
2017; Sanjib and Sajal, 2013;Rajani and 
Purnima, 2009). Epidemiological studies 
have associated arsenic exposure with ele-
vated risks of hypertension (Grau-Perez et 
al., 2017; Rahman et al., 1999; Chen et al., 
1995), carotid atheroslecrosis, ischemic 
heart disease (Abdul et al., 2015; Hsueh et 
al., 1998; Tseng et al., 2003), and vascular 
disease mortality (Valko et al., 2016; Chen et 
al., 1996).Studies have shown that arsenic 
treatment induced hepatic injury via altera-
tions of lipid profiles with noticeable altera-
tions in liver function. The results of this 
study showed that there was a significant 
(p<0.05) difference in the TAG, cholesterol 
and phospholipids levels at varying concen-
trations in the hepatic tissues which could 
be as a result of steatosis or ATP depletion 
supported by the findings of Gresser 
(1981); Liu and Waalkes (2008) whose find-
ings indicated arsenic as a cause of change 
in liver fats due to ATP depletion. Cardiac 
TAG and phospholipids levels were signifi-
cantly increased as a result of arsenic expo-
sure from our study leading to hyper-
lipidemia which can result in cardiovascular 
diseases. Our findings support arsenic expo-
sure to cause cardiovascular diseases as re-
ported by Bambino et al. (2017);Valko et al. 
(2016); Balakumar and Kaur (2009); Wang 
et al. (2002).  Diseased conditions of the 
liver and/or mal-absorbtion can lead to de-
creased levels of nutrients (Criqui, 1994). 
We observed hepatic hypocholesterolemia 
in rats exposed to arsenic after 5 weeks. 
This could be linked in part to malabsorp-
tion and alteration of membrane integrity as 
observed by decreased hepatic phospholipids 
levels after exposure for 15 weeks. 
 
Electrolyte balance is necessary for normal 
functioning of cells and organs. Fluid and 
electrolyte homeostasis occurs when fluids 
and electrolytes balance is maintained within 
narrow limits despite a wide variety in dietary 
intake, metabolic rate and kidney function. 
Previous studies by Shafaq and Tabassum 
(2008), reported that cisplatin disturbed bal-
ance between oxidation and antioxidation 
mechanism which consequently affect the 
membrane electrolytes revealing that disturb-
ance occur in plasma and membrane electro-
lytes in cisplatin treated rats. This present 
study showed exposure to DMA can cause 
Na+ and K+ ion imbalance in liver, kidney, 
brain and heart. 
 
A significant decrease (p<0.05) in Na+ in the 
renal tissues with both 20 and 40ppm during 
arsenic exposure for 15 weeks was observed 
when compared with the control group lead-
ing to hyponatremia as reported by Anand 
and Saxena (2015), which could be as a result 
of degeneration of the kidney tissue, caused 
by the attachment of DMA with the protein 
of the renal tubular epithelium as reported 
by Chandrakar et al. (2017); Schnellmann and 
Kelly (2008) and thus movement of ATPase 
from basolateral to apical membrane. This 
produces reactive oxygen species (ROS) 
which was reported to cause peroxidation of 
unsaturated fatty acids in biological mem-
branes (Schnellmann and Kelly, 2008). This 
effect leads to decrease in membrane fluidity 
and membrane integrity which delocalizes 
the enzymes Na+/K+ ATPase which is in-
volved in the transportation of the ion. This 
effect thus resulted in decreased reabsorp-
tion causing increased urinary loss of the ion 
(Ajai et al., 2013). This can cause electrolytes 
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imbalance as observed in our results. 
 
The observed significant (p<0.05) decrease 
in K+in the cardiac tissues at both 20ppm 
and 40ppm (15weeks) could cause the heart 
muscle not to relax between breath because 
K+ is an essential ion required for this pro-
cess. There could be decrease in the activity 
of some enzymes required in energy metab-
olism such as kinases and this could eventu-
ally lead to irregular heartbeat and there 
would be a decrease in the capacity of the 
heart to pump blood, because these pro-
cesses require energy (Taber and Venes, 
2009). High intracellular K+ is essential for 
important metabolic functions which in-
clude protein biosynthesis by ribosome; 
there could be a disruption in the biosyn-
thesis of protein by the cardiac cells (Anand 
and Saxena 2015). 
 
In the hepatic tissues, Ca2+ concentration 
was significantly increased in all exposed 
groups while a significant (p<0.05) decrease 
was observed in the renal tissue (5 and 
15weeks). This may be due to the impair-
ment of either net electrolytes influx or he-
patic/renal function as reported by Rogers 
et al. (2003) and disruption of the cell mem-
brane permeability (Murray et al., 2000). The 
impairment in the flux of Ca2+ in the body 
could also pose a threat to muscle contrac-
tion, transmission of nerve impulses and in 
neuromuscular excitability (Malhotra, 1998). 
Reduced extracellular Ca2+ increases the 
irritability of nerve tissue, and very low lev-
els may cause spontaneous discharge of 
nerve impulses leading to tetany and con-
vulsions (Hays and Swenson, 1985; Mal-
hotra 1998; Murray et al., 2000). 
 
CONCLUSION 
Results from this study showed that arsenic 
in form of DMA at 20 ppm and 40 ppm 
can cause electrolytes imbalance and 
dyslipidemia in hepatic, renal, brain and car-
diac tissues of male albino rats. 
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